Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 24 January 2026

IBM stock price dips into the weekend as investors brace for Jan. 28 earnings

IBM stock price dips into the weekend as investors brace for Jan. 28 earnings

IBM shares fell 0.76% to $292.44 Friday and slipped further after hours ahead of its January 28 earnings report. Investors await fourth-quarter results and guidance, focusing on software and consulting tied to new AI services. IBM Consulting has launched an internal AI delivery platform, but executives warn that scaling real value remains difficult. The company will hold its earnings call Wednesday at 5 p.m. ET.
24 January 2026
··
AstraZeneca stock faces a new test: Iraq terrorism lawsuit revived with NYSE move days away

AstraZeneca stock faces a new test: Iraq terrorism lawsuit revived with NYSE move days away

A U.S. appeals court on Friday revived a lawsuit accusing AstraZeneca and other firms of funding terrorism in Iraq. The ruling was announced after U.S. markets closed; AstraZeneca shares had closed up 1.37% in New York and 0.15% in London. The company plans to switch its U.S. listing from Nasdaq to NYSE on Jan. 30. Investors await Monday’s market reaction.
24 January 2026
··
Morgan Stanley stock slides into weekend as Fed decision, SpaceX IPO talk loom

Morgan Stanley stock slides into weekend as Fed decision, SpaceX IPO talk loom

Morgan Stanley shares fell 2.2% to $179 Friday, underperforming major indexes as bank stocks broadly declined. Goldman Sachs dropped 3.7%, JPMorgan Chase nearly 2%, and Bank of America 1.4%. The S&P 500 was flat, while the Dow lost 0.58%. Investors await the Federal Reserve’s Jan. 28 decision and earnings from Apple, Microsoft, Meta, and Tesla next week.
24 January 2026
···
Novo Nordisk Class B stock heads into Monday with Wegovy pill scripts and Victoza lawsuit in focus

Novo Nordisk Class B stock heads into Monday with Wegovy pill scripts and Victoza lawsuit in focus

Novo Nordisk Class B shares closed up 1.17% at 401.35 crowns in Copenhagen, lifted by strong early U.S. demand for its new Wegovy pill. The company faces a new U.S. lawsuit alleging a “pay-for-delay” scheme for Victoza. Over 18,000 Wegovy pill prescriptions were reported in the U.S. since its Jan. 5 launch. Indian regulators approved local firms to make generic semaglutide ahead of the 2026 patent expiry.
24 January 2026
··
GE Aerospace stock slides after earnings selloff — what to watch before Monday

GE Aerospace stock slides after earnings selloff — what to watch before Monday

GE Aerospace shares fell 0.4% to $293.87 Friday, capping a 9.6% slide over five sessions after its fourth-quarter results and 2026 outlook missed analyst profit estimates. Orders jumped 74% to $27 billion, while adjusted revenue rose 20% to $11.9 billion. CEO H. Lawrence Culp Jr. defended pricing and highlighted a $190 billion backlog. Analysts called the drop a valuation reset, not a shift in the engine cycle.
24 January 2026
··
1 … 330 331 332 333 334 … 1,947

Stock Market Today

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop